Analysis of risk factors of thyroid cancer

doi:10.3760/cma.j.issn.1673-422X.2017.04.011

Abstract

Abstract: In the last decades, the incidence of thyroid cancer has continuously and rapidly increased, and the risk factors have become the focus of the whole society′s attention. The exposure of radiation in childhood and genetic predisposition are determinate risk factors for thyroid cancer. Goiter, benign nodules/adenomas and obesity are highly likely risk factors for thyroid cancer. Some menstrual and reproductive factors and dietetic factors are possible risk factors for thyroid cancer.

Key words: Thyroid neoplasms, Morbidity, Risk factors

Wang Jiafeng, Ge Minghua.. Analysis of risk factors of thyroid cancer[J]. Journal of International Oncology, 2017, 44(4): 284-286.

References

［1］ Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies［J］. Radiat Res, 2012, 178(2): AV43-AV60. DOI: 10.1667/RRAV05.1. ［2］ Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer［J］. Radiat Res, 2012, 178(4): 365-376. DOI: 10.1667/RR2889.1. ［3］ Williams D. Radiation carcinogenesis: lessons from chernobyl［J］. Oncogene, 2008, 27 Suppl 2: S9-S18. DOI: 10.1038/onc.2009.349. ［4］ Cardis E, Howe G, Ron E, et al. Cancer consequences of the chernobyl accident: 20 years on［J］. J Radiol Prot, 2006, 26(2): 127-140. DOI: 10.1088/09524746/26/2/001. ［5］ Memon A, Godward S, Williams D, et al. Dental x-rays and the risk of thyroid cancer: a case-control study［J］. Acta Oncol, 2010, 49(4): 447-453. DOI: 10.3109/02841861003705778. ［6］ Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence［J］. Epidemiology, 2009, 20(2): 181-187. DOI: 10.1097/EDE.0b013e318196ac1c. ［7］ Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American thyroid association［J］. Thyroid, 2009, 19(6): 565-612. DOI: 10.1089/thy.2008.0403. ［8］ Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer［J］. J Clin Endocrinol Metab, 2005, 90(10): 57475753. DOI: 10.1210/jc.2005-0935. ［9］ dos Santos Silva I. Swerdlow AJ. Sex differences in the risks of hormonedependent cancers［J］. Am J Epidemiol, 1993, 138(1): 10-28. ［10］ Negri E, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer-Ⅰ. Methods［J］. Cancer Causes Control, 1999, 10(2): 131-142. DOI: 10.1023/A:1008851613024. ［11］ Dal Maso L, Bosetti C, La Vecchia C, et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors［J］. Cancer Causes Control, 2009, 20(1): 75-86. DOI: 10.1007/s10552-008-9219-5. ［12］ Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer［J］. Cancer Causes Control, 1999, 10(6): 583-595. ［13］ Singh B, Shaha AR, Trivedi H, et al. Coexistent hashimoto′s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome［J］. Surgery, 1999, 126(6): 1070-1076; discussion-1076-1077. ［14］ Kim KW, Park YJ, Kim EH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto′s thyroiditis［J］. Head Neck, 2011, 33(5): 691-695. DOI: 10.1002/hed.21518. ［15］ Anil C, Goksel S, Gursoy A. Hashimoto′s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid no-dules: a single-center prospective study［J］. Thyroid, 2010, 20(6): 601-606. DOI: 10.1089/thy.2009.0450. ［16］ Jankovic B, Le KT, Hershman JM. Clinical review: hashimoto′s thyroiditis and papillary thyroid carcinoma: is there a correlation?［J］. J Clin Endocrinol Metab, 2013, 98(2): 474-482. DOI: 10.1210/jc.2012-2978. ［17］ Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies［J］. Endocr Relat Cancer, 2009, 16(1): 17-44. DOI: 10.1677/ERC-08-0154. ［18］ Bosetti C, Kolonel L, Negri E, et al. A pooled analysis of case-control studies of thyroid cancer. Ⅵ. Fish and shellfish consumption［J］. Cancer Causes Control, 2001, 12(4): 375-382. ［19］ Bosetti C, Negri E, Kolonel L, et al. A pooled analysis of case-control studies of thyroid cancer. Ⅶ. Cruciferous and other vegetables (International) ［J］.Cancer Causes Control, 2002, 13(8): 765-775. ［20］ FeldtRasmussen U. Iodine and cancer［J］. Thyroid, 2001, 11(5): 483-486. DOI: 10.1089/105072501300176435. ［21］ Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood［J］. J Natl Cancer Inst, 2005, 97(10): 724-732. DOI: 10.1093/jnci/dji129. ［22］ Knobel M, Medeiros-Neto G. Relevance of Iodine intake as a reputed predisposing factor for thyroid cancer［J］. Arq Bras Endocrinol Metabol, 2007, 51(5): 701-712. ［23］ Xu L, Port M, Landi S, et al. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three casecontrol studies［J］. Thyroid, 2014, 24(6): 966-974. DOI: 10.1089/thy.2013.0566. ［24］ Bhaskaran K, Douglas I, Forbes HA, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults［J］. Lancet, 2014, 384(9945): 755-765. DOI: 10.1016/S0140-6736(14)60892-8.

[1]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[2]	Zhao Xin, Fan Xuewu, Tian Long, Hu Yimin. Application and evaluation study of 3D ultrasound in image guided radiotherapy for prostate cancer [J]. Journal of International Oncology, 2024, 51(1): 43-49.
[3]	Deng Juanjun, Zhao Dayong, Li Miao. Adverse reactions and risk factors of immune checkpoint inhibitors in the treatment of non-small cell lung cancer [J]. Journal of International Oncology, 2023, 50(9): 564-568.
[4]	Zhang Jinnan, Liu Bangqing, Li Jun, Liu Xiaohui. Research on BHLHE40 targets HMGA2 to reduce the sensitivity of thyroid cancer cells to cisplatin through activating the oxidative phosphorylation pathway [J]. Journal of International Oncology, 2023, 50(7): 398-406.
[5]	Yang Lirong, Wang Yufeng. Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer [J]. Journal of International Oncology, 2023, 50(4): 220-226.
[6]	Jiao Panpan, Xue Lijuan, Zhan Juan. Risk factors and predictors of immune-related adverse events induced by immune checkpoint inhibitors [J]. Journal of International Oncology, 2023, 50(12): 739-744.
[7]	Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun. Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model [J]. Journal of International Oncology, 2022, 49(9): 532-536.
[8]	Zhang Yan, Pan Lei, Liu Shuting. Establishment of an efficacy prediction model for gefitinib in non-small cell lung cancer patients based on ABCB1 and ABCG2 gene polymorphisms [J]. Journal of International Oncology, 2022, 49(6): 327-333.
[9]	Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao. Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients [J]. Journal of International Oncology, 2022, 49(2): 79-83.
[10]	Li Jinhao, Wang Guidong, Li Xuefei, Liu Zilin, Meng Kailong. Clinical study of venous phase CT value in predicting central group lymph node metastasis of papillary thyroid carcinoma [J]. Journal of International Oncology, 2022, 49(10): 581-585.
[11]	Wu Yuping, Zhang Xiaoyu, Lu Keyi. Mechanism of PD-L1 in thyroid carcinoma and its application in diagnosis and treatment [J]. Journal of International Oncology, 2021, 48(9): 560-563.
[12]	Feng Zhiping, Yang Chuanzhou, Chen Ting, Zhu Jialun, Liu Chao, Lyu Juan, Lu Jianmei, Deng Zhiyong. BRD4 inhibitor specifically inhibits the development of wild-type Kras differentiated thyroid carcinoma by regulating BRD4/miR-106b-5p/P21 axis [J]. Journal of International Oncology, 2021, 48(8): 463-472.
[13]	Wang Hui, Xia Rong, Wei Qingwen, Wan Yixin. Risk factors and predictive biomarkers of immune checkpoint inhibitor-associated pneumonia in non-small cell lung cancer [J]. Journal of International Oncology, 2021, 48(5): 296-301.
[14]	Hou Xiaofeng, Xue Jincai, Tian Youxin, Liu Qinjiang. Diagnosis and surgical treatment of differentiated thyroid carcinoma in 40 years [J]. Journal of International Oncology, 2020, 47(8): 449-456.
[15]	Cheng Hu, Liu Mingkui, Chen Tianping. Effects of lncRNA AFAP1-AS1 on proliferation and invasion of thyroid cancer cells and its mechanisms [J]. Journal of International Oncology, 2020, 47(6): 327-332.